Keywords: orion, pharma, 2nd-qtr, net, sales, up, finnish
Orion Pharma 2nd-qtr net sales up 8.1%
Article | 13 August 2001
Finnish drugmaker Orion Pharma has posted an 8.1% rise in second-quarter2001 net sales to 230.5 million euros ($203.3 million). Product sales expanded more ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
